Study: 37% of Australian Medical Cannabis Users Have Prescription
Mon / Mar 27th
A recent study found that 37% of medical cannabis patients in Australia have a legal prescription for the plant, up from just 2.5% in 2018.
As of 2016, Australia has legalized the use of medical marijuana, and this means cannabis businesses and entrepreneurs are looking to expand in the new market. Below are articles that relate to the Australian marijuana industry.
Mon / Mar 27th
A recent study found that 37% of medical cannabis patients in Australia have a legal prescription for the plant, up from just 2.5% in 2018.
Tue / Feb 7th
Australia’s Therapeutic Goods Administration announced the legalization of medical psilocybin and MDMA for depression and PTSD, respectively, starting July 1.
Wed / Sep 28th
In less than a decade, the cannabis industry has gone from seeing a worldwide blanket prohibition of the plant to today, where new and exciting cannabis opportunities can be found across the globe.
Wed / Sep 28th
Australian regulators issued 73 citations totaling nearly AUD$1 million to medical cannabis companies that claimed their products could treat serious medical conditions.
Fri / Jul 15th
For the first time in Australia, cannabis use has garnered more support than tobacco use, as reported by a recent National Drug Strategy Household Survey by the Australian Institute of Health.
Wed / Dec 29th
The recent National Drug Strategy Household Survey in Australia found that 41.1% of respondents believe cannabis should be legalized.
Thu / Aug 19th
Cannabis use in Australia spiked during the coronavirus pandemic while the use of alcohol and methamphetamine has dropped, according to new research.
Tue / Apr 13th
Researchers at the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics found via a meta-analysis of 80 separate studies that cannabis impairment lasts on average somewhere between 3 and 10 hours.
Thu / Mar 25th
The Faculty of Pain Medicine at the Australian and New Zealand College of Anesthetists is telling physicians not to recommend medical cannabis for chronic pain due to a lack of evidence.
Mon / Feb 8th
Cann Group Limited in Australia said last week it lost $3.6 million when payments meant for an overseas contractor were, “received by an unknown third party as a result of a complex and sophisticated cyber fraud.”
Mon / Dec 21st
The Australian biotech company Neurotech International Ltd. announced it has completed studies using human brain cells to investigate the anti-inflammatory and neuro-modulatory properties of two proprietary cannabis strains.
Tue / Dec 8th PRESS RELEASE
Investors and cannabis stocks the world over have been buoyed by positive regulatory news from the United States, with the… Read More
Fri / Sep 18th
Australian researchers found a 14-25 percent reduction in chemotherapy side effects in patients who received cannabis capsules during a recent study.
Fri / Sep 11th PRESS RELEASE
Australia’s cannabis stocks have reacted positively to news of the Therapeutic Goods Administration (TGA) interim decision to pave the way… Read More
Fri / Jul 17th
Australia’s National Drug Strategy Household Survey found that just 3.9 percent of Australians who used medical cannabis last year obtained it legally via a prescription.
Tue / Jul 7th
Cann Group in Victoria, Australia has secured a government-funded jobs grant for $1.97 million to upgrade its cultivation/production facility, which could generate 150 local jobs.
Thu / Jun 4th
FSD Pharma has received FDA permission to design and submit an application for a new trial using a synthetic cannabinoid-based drug in the treatment of COVID-19.
Fri / Apr 10th
Australian researchers have uncovered evidence that a cannabis-based treatment could be effective against chronic insomnia.
Thu / Apr 9th
A new financial analysis suggests that the Oceanic cannabis market including New Zealand, Australia, Guam, and surrounding islands could be worth $1.55 billion by 2024.
Fri / Jan 31st
Major cannabis reforms in the Australian Capital Territory have taken effect, despite opposition from the federal government and a United Nations warning that the reforms violate international drug treaties.
Tue / Jan 28th PODCAST
Benjamin Jesse is the founder of the Australian Cannabis Industry Awards, an event that celebrates Australia’s cannabis industry and highlights successful leaders in the space.
Wed / Dec 11th PRESS RELEASE
Creso Pharma Ltd (ASX: CPH) has established itself as an early mover within the medicinal cannabis sector, as the global cannabis market is expected to reach US$272 billion within the decade.
Mon / Oct 28th
UN officials have sent a letter warning Australia’s federal government that the cannabis legalization language recently adopted in the Australian Capital Territory breaches at least three international drug conventions signed by the nation.
Mon / Oct 21st
Recent cannabis reforms legalizing possession and home cultivation in the Australia Capital Territory will have “no effect” because it does not address differences in federal law, says Australian Attorney-General Christian Porter.
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.